Shanghai Labway Clinical Laboratory Co Ltd (301060) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.081x

Based on the latest financial reports, Shanghai Labway Clinical Laboratory Co Ltd (301060) has a cash flow conversion efficiency ratio of 0.081x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥135.78 Million ≈ $19.87 Million USD) by net assets (CN¥1.67 Billion ≈ $244.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 301060 market cap overview for the company's overall valuation and market capitalisation.

Shanghai Labway Clinical Laboratory Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Shanghai Labway Clinical Laboratory Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Labway Clinical Laboratory Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Labway Clinical Laboratory Co Ltd ranked by their cash flow conversion efficiency. Explore Shanghai Labway Clinical Laboratory Co L (301060) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Patrizia AG XETRA:PAT	0.038x
H&R Century Union Corp SHE:000892	-0.020x
Xinjiang Yilite Industry Co Ltd SHG:600197	-0.016x
mobilezone ag SW:MOZN	-1.383x
Carlton Investments Ltd AU:CIN	0.025x
Chipsea Technologies Shenzhen Corp Ltd SHG:688595	-0.046x
SK Discovery Co Ltd KO:006120	0.036x
Anpec Electronics TWO:6138	0.041x

Annual Cash Flow Conversion Efficiency for Shanghai Labway Clinical Laboratory Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2025. View 301060 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.64 Billion ≈ $240.69 Million	CN¥268.85 Million ≈ $39.34 Million	0.163x	+37.55%
2024-12-31	CN¥1.82 Billion ≈ $266.37 Million	CN¥216.31 Million ≈ $31.65 Million	0.119x	-56.98%
2023-12-31	CN¥1.98 Billion ≈ $289.76 Million	CN¥546.99 Million ≈ $80.04 Million	0.276x	+645.91%
2022-12-31	CN¥2.27 Billion ≈ $332.58 Million	CN¥84.17 Million ≈ $12.32 Million	0.037x	-72.83%
2021-12-31	CN¥1.64 Billion ≈ $239.96 Million	CN¥223.51 Million ≈ $32.71 Million	0.136x	+1.28%
2020-12-31	CN¥1.25 Billion ≈ $182.53 Million	CN¥167.87 Million ≈ $24.57 Million	0.135x	+131.24%
2019-12-31	CN¥1.21 Billion ≈ $177.52 Million	CN¥70.60 Million ≈ $10.33 Million	0.058x	-62.80%
2018-12-31	CN¥1.18 Billion ≈ $172.83 Million	CN¥184.79 Million ≈ $27.04 Million	0.156x	+280.90%
2017-12-31	CN¥1.10 Billion ≈ $161.60 Million	CN¥-95.52 Million ≈ $-13.98 Million	-0.086x	-295.93%
2016-12-31	CN¥614.70 Million ≈ $89.95 Million	CN¥27.14 Million ≈ $3.97 Million	0.044x	-83.09%
2015-12-31	CN¥305.25 Million ≈ $44.67 Million	CN¥79.70 Million ≈ $11.66 Million	0.261x	+163.44%
2014-12-31	CN¥201.13 Million ≈ $29.43 Million	CN¥-82.77 Million ≈ $-12.11 Million	-0.412x	-3402.03%
2013-12-31	CN¥130.79 Million ≈ $19.14 Million	CN¥1.63 Million ≈ $238.52K	0.012x	--

About Shanghai Labway Clinical Laboratory Co Ltd

SHE:301060 China Diagnostics & Research

Market Cap

$644.10 Million

CN¥4.40 Billion CNY

Market Cap Rank

#11061 Global

#3085 in China

Share Price

CN¥10.99

Change (1 day)

+1.20%

52-Week Range

CN¥8.05 - CN¥13.68

All Time High

CN¥52.42